References
- Boer A. G., De Gubbens-Stibbe J. M., Breimer D. D. Avoidance of first pass elimination of propranolol after rectal administration to rats. Journal of Pharmacy and Pharmacology 1981; 33: 50–51
- Bollman J. L., Cain J. C., Grindley J. H. Techniques for the collection of lymph from the liver, small intestine or thoracic duct of the rat. Journal of Laboratory and Clinical Medicine 1948; 33: 1349–1352
- Ganguly J. Absorption of vitamin A. American Journal of Clinical Nutrition 1969; 22: 923–933
- Garceau Y., Davis I., Hasegawa J. Plasma propranolol levels in beagle dogs after administration of propranolol hemisuccinate ester. Journal of Pharmaceutical Science 1978; 67: 1360–1363
- Gibaldi M., Kanig J. L. Absorption of drugs through the oral mucosa. Journal of Oral Therapeutics and Pharmacology 1965; 1: 440–450
- Grimus R. C., Schuster I. The role of the lymphatic transport in the enteral absorption of naftifine by the rat. Xenobiotica 1984; 14: 287–294
- Hatch F. T., Lees R. S. Practical methods for plasma lipoprotein analysis. Advances in Lipid Research, R. Paoletti, D. Kritchevsky. Academic Press, New York 1968; vol. 6: 1–68
- Heagerty A. M., Donovan M. A., Castleden C. M., Pohl J. F., Patel L., Hedges A. Influence of cimetridine on pharmacokinetics of propranolol. British Medical Journal 1981; 282: 1917–1919
- Hendrix B. M., Sweet J. E. A study of amino nitrogen and glucose in lymph and blood before and after the injection of nutrient solutions in the intestine. Journal of Biological Chemistry 1917; 32: 299–307
- Ichihashi T., Kinoshita H., Shimamura K., Yamada H. Absorption and disposition of epithiosteroids in rats [1]: Route of administration and plasma levels of epitiostanol. Xenobiotica 1991; 21: 865–872
- Komeno T., Hayashi S., Ishihara S., Itani H., Iwakura H., Takeda K. Studies on 2α,3α-epithio-5α-androstan-17β-ol and related compounds. Part I Syntheses. Annual Report of Shionogi Research Laboratories 1969; 19: 3–19
- Lai C. M., Mason W. D. New compounds: synthesis of alkyl esters of D,L-dopa. Journal of Pharmaceutical Science 1973; 62: 510–511
- McLean A. J., Skews H., Bobok A., Dudley F. J. Interaction between oral propranolol and hydrolazine. Clinical Pharmacology and Therapeutics 1980; 27: 726–732
- Muranashi S. Lymphatic delivery of drugs and its application to cancer chemotherapy. Yakugaku Zasshi 1980; 100: 687–698
- Noguchi T., Jinguji Y., Kimura T., Muranishi S., Sezaki H. Mechanism of the intestinal absorption of drugs from oil-in-water emulsions. VII. Role of bile in the lymphatic transport of lipid-soluble compounds from triolein emulsions. Chemical and Pharmaceutical Bulletin 1975; 23: 782–786
- Noguchi T., Charman W. N. A., Stella V. J. The effect of drug lipophilicity and lipid vehicles on the lymphatic absorption of various testosterone esters. International Journal of Pharmaceutics 1985; 24: 173–184
- Palin K. J., Wilson C. G., Davis S. S., Phillips A. J. The effect of oils on the lymphatic absorption of DDT. Journal of Pharmacy and Pharmacology 1982; 34: 707–710
- Pocock D. M. E., Vost A. DDT absorption and chylomicron transport in rat. Lipids 1974; 9: 374–381
- Sasaiiara K., Nitanai T., Habara T., Kojima T., Kawahara Y., Morioka T., Nakajima E. Dosage form design for improvement of bioavailability of levodopa. IV: Possible causes of low bioavailability of oral levodopa in dogs. Journal of Pharmaceutical Sciences 1981; 70: 730–733
- Sieber S. M., Cohn V. H., Wynn W. T. The entry of foreign compounds into the thoracic duct lymph of the rat. Xenobiotica 1974; 4: 265–284
- Zilversmit D. B. The surface coat of chylomicrons: lipid chemistry. Journal of Lipid Research 1968; 9: 180–186